Martin L Moore

Title: Martin L. Moore: Innovator in Respiratory Syncytial Virus Research

Introduction

Martin L. Moore is a prominent inventor based in Decatur, GA, known for his significant contributions to the field of virology, particularly in the development of vaccines for respiratory syncytial virus (RSV). With a total of nine patents to his name, Moore has made substantial advancements in immunogenic compositions and methods of use.

Latest Patents

Among his latest patents, one notable invention is related to chimeric respiratory syncytial virus (RSV), which includes live attenuated vaccines and immunogenic compositions. This patent discloses a chimeric RSV with a specific mutated gene pattern encoding an RSV F protein with particular amino acid substitutions. Another significant patent focuses on recombinant RSV with silent mutations, detailing polynucleotide sequences and isolated or recombinant nucleic acids and polypeptides. These innovations are aimed at creating effective vaccines and immunogenic compositions suitable for combating RSV.

Career Highlights

Throughout his career, Martin L. Moore has worked with esteemed institutions such as Emory University and Children's Healthcare of Atlanta, Inc. His work has been pivotal in advancing the understanding and treatment of respiratory viruses, particularly in developing effective vaccines.

Collaborations

Moore has collaborated with notable colleagues, including Anne Hotard and Jia Meng, contributing to a collaborative environment that fosters innovation and research in virology.

Conclusion

Martin L. Moore's contributions to the field of respiratory syncytial virus research highlight his role as a leading inventor in vaccine development. His innovative patents and collaborations continue to impact public health positively.